Compositions and methods of reducing dry mouth
US-9480635-B2 · Nov 1, 2016 · US
US9549951B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9549951-B2 |
| Application number | US-201614993324-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 12, 2016 |
| Priority date | Aug 31, 2012 |
| Publication date | Jan 24, 2017 |
| Grant date | Jan 24, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Materials capable of delivering stabilized free radicals to targeted treatment sites. The materials comprise semi-crystalline, hydrolytically degradable polymers that are subjected to ionizing radiation to create stabilized free radicals therein. Upon exposure to oxygen containing aqueous media, the materials generate reactive oxidative species which are useful in biological processes.
Opening claim text (preview).
What is claimed is: 1. A biocompatible device capable of releasing superoxide comprising: a substrate; and a biocompatible material comprising at least one semi-crystalline, hydrolytically degradable polymeric material, the polymeric material having been subjected to ionizing radiation at a dose rate less than about 50 kGy and sterilized by non-ionizing radiation methods; said polymeric material being in contact with at least a portion of said substrate, wherein said at least one semi-crystalline, hydrolytically degradable polymeric material comprises a first polymeric material and a second polymeric material, wherein at least one of said first and second polymeric materials comprises stabilized free radicals; wherein said first polymeric material and said second polymeric material have been subjected to different doses of ionizing radiation, and wherein the biocompatible material, upon contact with aqueous media, enable multi-phasic generation of reactive oxidative species. 2. A biocompatible device capable of releasing superoxide comprising: a substrate; and a biocompatible material comprising at least one semi-crystalline, hydrolytically degradable polymeric material, the polymeric material having been subjected to ionizing radiation while maintained in an inert atmosphere; said polymeric material being in contact with at least a portion of said substrate, wherein said at least one semi-crystalline, hydrolytically, degradable polymeric material comprises a first polymeric material and a second polymeric material, wherein at least one of said first and second polymeric materials comprises stabilized free radicals; wherein said first polymeric material and said second polymeric material have been subjected to different doses of ionizing radiation, and wherein the biocompatible material, upon contact with aqueous media, enable multi-phasic generation of reactive oxidative species. 3. The biocompatible device of claim 1 , wherein the first polymeric material has a different hydrolytic degradation rate than the second polymeric material. 4. The biocompatible device of claim 1 , wherein the first polymeric material has a different degree of crystallinity than the second polymeric material. 5. The biocompatible device of claim 1 , wherein the first polymeric material comprises a different amount of stabilized free radicals than the second polymeric material. 6. The biocompatible device of claim 1 , wherein at least one of said first and second polymeric materials is bioabsorbable. 7. The biocompatible device of claim 6 , wherein the bioabsorbable polymer is selected from the group consisting of poly(dioxanone), poly(glycolide), poly(lactide) poly(ε-caprolactone), poly(anhydrides) such as poly(sebacic acid), poly(hydroxyalkanoates) such as poly(3-hydroxybutyrate), copolymers of any of these and combinations thereof. 8. The biocompatible device of claim 2 , wherein the first polymeric material has a different hydrolytic degradation rate than the second polymeric material. 9. The biocompatible device of claim 2 , wherein the first polymeric material has a different degree of crystallinity than the second polymeric material. 10. The biocompatible device of claim 2 , wherein the first polymeric material comprises a different amount of stabilized free radicals than the second polymeric material. 11. The biocompatible device of claim 2 , wherein at least one of said first and second polymeric materials is bioabsorbable. 12. The biocompatible device of claim 11 , wherein the bioabsorbable polymer is selected from the group consisting of poly(dioxanone), poly(glycolide), poly(lactide) poly(ε-caprolactone), poly(anhydrides) such as poly(sebacic acid), poly(hydroxyalkanoates) such as poly(3-hydroxybutyrate), copolymers of any of these and combinations thereof.
Peroxides · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title
Peroxy compounds, peroxides, e.g. hydrogen peroxide · CPC title
Particle radiation, e.g. electron-beam, alpha or beta radiation · CPC title
Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.